MICROLIFE WatchBP Home A (Professional Use) + SOFTWARE

- detection of atrial fibrillation (a specific cardiac arrhythmia)
- integrated ESH / AHA guidelines for taking accurate measurements at home that the doctor can rely on
- displays morning and evening averages and the total number of measurements
- clinically tested (BHS protocol)
- MAM technology (automatic triple measurement)
- stores up to 250 individual measurements in «NORMAL» mode.
- USB port and power socket
- low battery indicator
- 4 1.5 V AA batteries

Supplied with bag, USB cable, soft cuff 22-32 cm, software (GB) and manual (GB, IT, FR, DE). Other languages available on the web: ES, DK, GR, FI, NL, NO, RU, SE, UA).

Extra-large display
Dimensions: 150 x 100 x 50 mm
Weight: 385 g

1 piece. Microlife AFIB Technology:
An innovative, patented technology for the early diagnosis of atrial fibrillation (AF)
More than 30000 strokes can be prevented within the European Union by using Microlife AFIB Technology in primary care.
The new Microlife AFIB technology enables simultaneous measurement of blood pressure and screening for atrial fibrillation.
Microlife AFIB Technology detects atrial fibrillation with high sensitivity (97-100%) and specificity (89%), as demonstrated in several clinical studies.
The NICE guidelines for "The diagnosis and assessment of hypertension" recommend the use of AFIB screening for routine blood pressure measurement by general practitioners.
Screening for atrial fibrillation is recommended for patients at home while monitoring blood pressure.